Post-Covid-19 Arthritis | ||||
| Benha Journal of Applied Sciences | ||||
| Article 14, Volume 7, Issue 11, November 2022, Page 83-92 PDF (445.87 K) | ||||
| Document Type: Original Research Papers | ||||
| DOI: 10.21608/bjas.2022.293393 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| S.M. Khalil1; N.I. Hashaad2; R.EL- Tantawy2 | ||||
| 1Rheumatology, Rehabilitation and Physical Medicine., Dept., Faculty of Medicine, Tanta Univ., Tanta, Egypt | ||||
| 2Rheumatology, Rehabilitation and Physical Medicine ., Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
| Abstract | ||||
| The majority of documented cases of arthritis occurred between 2 and 4 weeks following the discovery of COVID positive. These cases mostly involved the minor joints of the hands. Rheumatoid arthritis, psoriatic arthritis, vasculitis, systemic sclerosis, septic arthritis, and post-covid flares of preexisting inflammatory arthritis are all examples of post-Covid-19 arthritis. Patients with COVID-19 vaccination-related new-onset arthritis, arthralgias, joint disease flare-up, and bursitis often experience joint swelling, discomfort, stiffness, and possibly restricted range of motion. Molecular mimicry, the generation of specific autoantibodies, and the involvement of certain vaccine adjuvants are the primary processes by which the COVID-19 vaccine causes autoimmune. The purpose of this paper was to provide a summary and clarify recent developments in our understanding of arthritis after COVID-19. | ||||
| Keywords | ||||
| Covid-19; Post-Covid-19; Arthritis; Vaccination | ||||
|
Statistics Article View: 87 PDF Download: 233 |
||||
